Euro
USD
British Pound
NULL
Product Description
SARS-CoV-2 (COVID-19) Full-Length Beta Variant (B.1.351, SA) Spike Recombinant Protein | 21-819 | ProSci
Tested Application: E
Application: This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only.
Tpredicted Molecular Weight: 1286 amino acids (including Rho1D4 tag and linker); 142114 Da
Physical State: Liquid
Buffer: 20 mM Hepes pH 7.5; 150 mM NaCl, 0.001 % LMNG
Storage Condition: –80˚C. Avoid freeze-thaw cycles
Alternate Name: SARS-CoV-2 (COVID-19) Spike Recombinant Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein
Background: N/A
Shipping: Dry Ice
Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.
Source: HEK293 cells
Species: SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Protein
By Source: Human Cells
By Species: Other
Fusion Tag: C-terminal Rho1D4
Sequence: del 144, K417N, E484K, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H
furin cleavage site “RRAR” mutated to “GSAG”; KV986PP
C-terminal Rho1D4 tag fused with spacer “GSSG” to protein sequence
Bological Activity: not determined
Purity: >98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Rho1D4 Agarose.
